NUS Other Stockholder Equity from 2010 to 2025

NUS Stock  USD 7.53  0.97  14.79%   
Nu Skin Other Stockholder Equity yearly trend continues to be comparatively stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. From the period from 2010 to 2025, Nu Skin Other Stockholder Equity quarterly data regression had mean square error of 20511.6 T and mean deviation of  237,387,837. View All Fundamentals
 
Other Stockholder Equity  
First Reported
1995-12-31
Previous Quarter
-942.6 M
Current Value
-939.2 M
Quarterly Volatility
378.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.076 or PTB Ratio of 1.28. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
  
Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Nu Skin Enterprises over the last few years. It is Nu Skin's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

NUS Other Stockholder Equity Regression Statistics

Arithmetic Mean(666,726,449)
Coefficient Of Variation(42.81)
Mean Deviation237,387,837
Median(774,041,000)
Standard Deviation285,451,461
Sample Variance81482.5T
Range957.4M
R-Value(0.87)
Mean Square Error20511.6T
R-Squared0.77
Slope(52,442,546)
Total Sum of Squares1222238.1T

NUS Other Stockholder Equity History

2025-811 M
2024-853.7 M
2023-948.6 M
2022-955.8 M
2021-925.2 M
2020-881.8 M
2019-767.3 M

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Stockholder Equity-853.7 M-811 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.